Prisym ID Launches FDA, MHRA Compliant Web-Based Solution
Prisym Medica is designed for life science companies that need to design, validate and approve labelling on a variety of products, from medical devices to pharmaceuticals and into
The US Food and Drug Administration (FDA) has approved two Jazz Pharmaceuticals regimens containing Ziihera (zanidatamab-hrii) for the first-line treatment of adults with unresectable, locally advanced or metastatic human epidermal growth factor receptor 2 (HER2)-positive gastroesophageal adenocarcinoma (GEA).